BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with ...

AI drug discovery cleared its first Phase IIa clinical test in 2025, as BIO 2026 confirmed the shift from speculation to ...

SAN CARLOS, CA / ACCESS Newswire / May 11, 2026 / Form Bio, a leader in AI-powered genetic medicine development and genome engineering, today announced the launch of FormManufacturing™, a new platform ...

AI systems are only as fair and safe as the data they’re built on. While conversations about AI ethics often focus on model architecture, algorithmic transparency or deployment oversight, fairness and ...

The last time I spoke about Upstream Bio, Inc. (UPB), it was in a Seeking Alpha article entitled "Upstream Bio: Maintaining Buy Rating On Verekitug Success In Phase 2 CRSwNP Study." With respect to ...

Data demonstrate favorable safety and tolerability profile, robust B-cell depletion, and encouraging platelet responses in heavily pretreated patients with primary immune thrombocytopenia Enrollment ...